Sign in

CIK 0001664710 · Non-accelerated filer<br>Smaller reporting company

Keros Therapeutics, Inc.

Sign in to watch
Ticker
KROS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
811173868
Phone
617-314-6297
Business address
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
  1. 8-K Event Regulation FD disclosure
  2. 8-K Event Results of operations
  3. 8-K Event Material agreement · Results of operations · Executive or director change · Regulation FD disclosure · Other events
  4. 8-K Event Other events
  5. 8-K Event Regulation FD disclosure
  6. 8-K Event Other events
  7. 8-K Event Executive or director change · Regulation FD disclosure · Other events
  8. 8-K Event Results of operations
  9. 8-K Event Other events
  10. 8-K Event Executive or director change
  11. 8-K Event Shareholder vote results · Other events
  12. 8-K Event Regulation FD disclosure
  13. 8-K Event Exit or restructuring costs · Other events
  14. 8-K Event Regulation FD disclosure
  15. 8-K Event Results of operations
  16. DEF 14A Proxy Proxy Statement
  17. 8-K Event Material agreement
  18. 8-K Event Material agreement · Shareholder rights changed · Bylaws or fiscal year change · Other events
  19. 8-K Event Other events
  20. 8-K Event Bylaws or fiscal year change

Page 2 of 9 · 168 filings